Efficacy and safety of alfosbuvir plus daclatasvir in Chinese patients with hepatitis C virus genotypes 1, 2, 3, and 6 infection: An open‐label, phase 2 study
暂无分享,去创建一个
Y. Guan | J. Niu | Yongfang Jiang | Hainv Gao | Yan Huang | Yuexin Zhang | Y. Xin | Liwen Zhao | Hong Ma | Rui Hua | Jiayun Chen | F. Kong | Q. Xiong | Xiaofeng Wen | Jie-fei Wang | Youwen Tan | Xian Zhang | Guangming Li | Xiaorong Mao | Cheng Li | Qiong Wu | C. Meng | B. Xu | Zhiqiang Wang | J. Niu | Bin Xu